Business
TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors
DURHAM, N.C., September 24, 2025--TruTechnologies announced Mirador Therapeutics executive Jordan Zwick joined its Board of Directors.
About this update from Bausch Health Companies Inc.
[{"type":"image","alt":"TruTechnologies announced Jordan Zwick joined its Board of Directors.","displaySize":"","headline":null,"caption":"TruTechnologies announced Jordan Zwick joined its Board of Directors.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":419,"url":"https://media.zenfs.com/en/business-wire.com/999139d04ee7007d592ffb4761413deb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/D9tva9ogIo3Ob4Lun3mHsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTgzODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/999139d04ee7007d592ffb4761413deb","width":480,"height":419}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3723,"height":983,"url":"https://media.zenfs.com/en/business-wire.com/a022b1e5ca13a0198445b59843bfd561"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8lFYs9At6DxWZSMz_vttHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a022b1e5ca13a0198445b59843bfd561","width":960,"height":253},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/2Xu5vwN7XDizmElcF9e3DA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02MzQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a022b1e5ca13a0198445b59843bfd561","width":1200,"height":317}}},{"type":"text","content":"DURHAM, N.C., September 24, 2025--(BUSINESS WIRE)--TruTechnologies, a leading provider of real-time clinical trial oversight, today announced Jordan Zwick joined its Board of Directors, bringing extensive experience in corporate strategy and business development to the Company.","length":278,"tagName":"p"},{"type":"text","content":"Jordan Zwick is Chief Business Officer and a founding team member at Mirador Therapeutics. He previously served as a strategic advisor to Prometheus Biosciences prior to its acquisition by Merck in 2023. He is on the Board of Directors of Theratechnologies Inc., where he played a central role in its recently announced acquisition by Future Pak.","length":346,"tagName":"p"},{"type":"text","content":"Earlier in his career, Mr. Zwick played a key role in the $14.5 billion sale of Salix Pharmaceuticals to what is now Bausch Health Companies in 2015. Post-sale, he went on to serve as Head of Strategy for the Salix business unit, overseeing business developme...